Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib (VS-6063).
$0.64 -0.00 (-0.40%)
As of 02/01/2023 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.